VANADATE has been reported to inhibit (Na+ + K+)-ATPase activity in membrane preparations from dog kidney1 and in red cells2. This inhibition, which occurs in the nanomolar concentration range in the presence of high Mg2+ concentrations and in the micromolar range at physiological Mg2+ concentrations2,3 is specific as other ATPase enzymes are not affected in these conditions1. Therefore vanadate has been suggested to be ‘an ideal specific regulator’ of (Na+ + K+)-ATPase1. We have shown4 that vanadate has a distinct positive inotropic effect in cat papillary muscle. It has been claimed that the positive inotropic action of cardiac glycosides, which are specific inhibitors of (Na+ + K+)-ATPase activity5,6, is associated with the inhibition of that enzyme. If that is so, vanadate would be expected to inhibit (Na+ + K+)-ATPase, in a concentration-dependent manner, in parallel with its effect on force of contraction. To test this hypothesis, we measured the effect of vanadate on (Na+ + K+)-ATPase activities and on 3H-ouabain-binding in identical conditions in a membrane preparation taken from cat hearts that were also used for experiments on contraction. We report here, however, that vanadate may stimulate (Na+ + K+)-ATPase activity transiently and 3H-ouabain-binding permanently in these conditions.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Cantley, L. C. Jr et al. J. biol. Chem. 252, 7421–7423 (1977).
Beaugé, L. A. & Glynn, I. M. Nature 272, 551–552 (1978).
Cantley, L. C. Jr Resh, M. D. & Guidotti, G. Nature 272, 552–554 (1978).
Hackbarth, I. et al. Nature 275, 67 (1978).
Skou, J. C. Physiol. Rev. 45, 596–617 (1965).
Schwartz, A., Lindenmayer, G. E. & Allen, J. C. Pharmac. Rev. 27, 3–134 (1975).
Pitts, B. J. R. & Schwartz, A. Biochim. biophys. Acta 401, 184–195 (1975).
Erdmann, E., Bolte, H.-D. & Lüderitz, B. Arch. Biochem. Biophys. 145, 121–125 (1971).
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. J. biol. Chem. 193, 265–275 (1951).
Erdmann, E. & Hasse, W. J. Physiol. 251, 671–682 (1975).
Quist, E. E. & Hokin, L. E. Biochim. biophys. Acta 511, 202–212 (1978).
Lee, K. S. & Yu, D. H. Biochem. Pharmac. 12, 1254–1264 (1963).
Peters, T., Raven, R.-H. & Wassermann, O. Eur. J. Pharmac. 26, 166–174 (1974).
Ghysel-Burton, J. & Godfraind, T. Br. J. Pharmac. 55, 249P (1975).
Cohen, I., Daut, J. & Noble, D. J. Physiol. 260, 75–103 (1976).
Godfraind, T. & Ghysel-Burton, J. Nature 265, 165–166 (1977).
Akera, T. Science 198, 569–574 (1977).
Cantley, L. C., Cantley, L. G. & Josephson, L. J. biol. Chem. 253, 7361–7368 (1978).
About this article
Cite this article
ERDMANN, E., KRAWIETZ, W., PHILIPP, G. et al. Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation. Nature 278, 459–461 (1979). https://doi.org/10.1038/278459a0
Science Signaling (2018)
Actions of vanadate on vascular tension and sodium pump activity in cat isolated cerebral and femoral arteries
British Journal of Pharmacology (1988)
Life Sciences (1983)
Effect of vanadium in the +5, +4 and +3 oxidation states on cardiac force of contraction, adenylate cyclase and (NA+ + K+)-ATPase activity
Biochemical Pharmacology (1982)
Effects of vanadium on different adenosinetriphosphatases and binding of3H‐labeled ouabain and calcium‐45 to rat brain synaptosomes
Journal of Toxicology and Environmental Health (1981)